SCHEMBL3746159

SCHEMBL3746159

O=C(O)C(c1ccc2c(c1)OCCO2)N1CCN2CCC[C@@H]2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
TSHR P16473 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CHRNA7 P36544 1/20 0.45
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
HTT P42858 3/20 0.43
GAA P10253 3/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KMT2A Q03164 3/20 0.42
TACR1 P25103 2/20 0.42
MEN1 O00255 2/20 0.42
GHSR Q92847 1/20 0.41
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3727187 0.80 TACR1 (0.50) ALDH1A1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL3735618 0.80 GHSR (0.69) ALDH1A1TSHRCYP1A2CYP3A4CYP2D6
SCHEMBL3635128 0.76 PTGS1 (0.57) ALDH1A1TSHRPTGS1PTGS2HTT
SCHEMBL3632586 0.74 GHSR (0.45) ALDH1A1TSHRCYP3A4CYP2D6CYP2C9
SCHEMBL3638382 0.73 GHSR (0.62) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3635603 0.73 GHSR (0.62) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL3635605 0.73 GHSR (0.62) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13044689 0.70 HRH3 (0.43) ALDH1A1TSHRGHSRKDM4E
SCHEMBL13044855 0.70 TSHR (0.42) ALDH1A1TSHRKMT2ATACR1MEN1
SCHEMBL13044717 0.70 HRH3 (0.43) ALDH1A1TSHRGHSRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R ALDH1A1 2645/4885TSHR 47/4885CYP1A2 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.